MedEdTalks - Ophthalmology - podcast cover

MedEdTalks - Ophthalmology

Vindico Medical Educationophthalmology.libsyn.com
MedEdTalks Ophthalmology is an accredited educational podcast for providers to learn more about treating patients with Ophthalmology diseases/disorders. Discover all content and topics by visiting mededtalks.com.
Last refreshed:
Follow this podcast in the Metacast mobile app to refresh it and see new episodes.
Download Metacast podcast app
Podcasts are better in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episodes

Targeting Angiopoietin-2 in DME: Efficacy and Safety Data With Drs. Carl Regillo and Nancy Holekamp

The angiopoietin/Tie2 pathway is an attractive therapeutic target for the management of retinal and choroidal vascular diseases, as it has been identified to play a role in vascular permeability and angiogenesis within the eye. Several therapies targeting this pathway have been investigated, and the FDA recently approved the first agent that inhibits both the angiopoietin-2 (Ang-2) and vascular endothelial growth factor (VEGF)-A pathways for the treatment of neovascular age-related macular degen...

May 31, 202217 minSeason 7Ep. 3

Targeting Angiopoietin-2 in nAMD: Efficacy and Safety Data With Drs. Carl Regillo and Arshad Khanani

The angiopoietin/Tie2 pathway is an attractive therapeutic target for the management of retinal and choroidal vascular diseases, as it has been identified to play a role in vascular permeability and angiogenesis within the eye. Several therapies targeting this pathway have been investigated, and the FDA recently approved the first agent that inhibits both the angiopoietin-2 (Ang-2) and vascular endothelial growth factor (VEGF)-A pathways for the treatment of neovascular age-related macular degen...

May 31, 202220 minSeason 7Ep. 2

The Tie2 Pathway and Its Role in the Pathophysiology of Retinal Vascular Disease With Drs. Carl Regillo and Judy Kim

The angiopoietin/Tie2 pathway is an attractive therapeutic target for the management of retinal and choroidal vascular diseases, as it has been identified to play a role in vascular permeability and angiogenesis within the eye. Several therapies targeting this pathway have been investigated, and the FDA recently approved the first agent that inhibits both the angiopoietin-2 (Ang-2) and vascular endothelial growth factor (VEGF)-A pathways for the treatment of neovascular age-related macular degen...

May 31, 202213 minSeason 7Ep. 1

Gel Stent Failure

This educational activity will review best practices regarding the use of gel stents in the treatment of glaucoma.

Dec 28, 202125 min

Cerebrospinal Fluid Pressure and Glaucoma

In this podcast, John R. Samples, MD, and Russell Swan, MD, discuss the relevance of cerebrospinal fluid pressure in the management of glaucoma.

Dec 16, 202124 min

Managing Ocular Surface Disease in Special Patient Populations With Drs. Lisa Nijm and Vance Thompson

This educational podcast will review important considerations for the diagnosis and management of ocular surface disease (OSD) in special patient populations. Faculty will provide pearls for preventing and managing OSD in individuals at elevated risk, including those undergoing ocular surgery, those with glaucoma or diabetes, as well as individuals on medications known to disrupt the ocular surface.

Jul 13, 202128 minSeason 1Ep. 1
Hosted on Libsyn
For the best experience, listen in Metacast app for iOS or Android